Company description

AXGN stands for AxoGen, Inc., a medical technology company focused on improving nerve repair and regeneration. The company specializes in developing and commercializing innovative products and surgical techniques to enhance nerve surgery outcomes. Their flagship product, Avance Nerve Graft, is a processed nerve allograft used to bridge nerve gaps and is the only commercially available processed nerve allograft for bridging long nerve gaps. AxoGen also offers a portfolio of nerve repair solutions including AxoGuard® Nerve Connector, AxoGuard® Nerve Protector, and AxoBioShield™, all aimed at providing solutions for nerve injuries. The company is dedicated to advancing the science of nerve repair through ongoing research and development efforts and collaborations with leading medical institutions. With a customer-centric approach, AxoGen prides itself on improving the quality of life for patients suffering from traumatic and surgical nerve injuries. They are committed to setting a high standard in this growing market, actively pursuing growth opportunities, and consistently delivering strong financial results. As a leader in the regenerative medicine industry, AXGN aims to revolutionize the field of nerve repair by continually innovating and providing superior products and solutions to healthcare professionals.